Shares of Poseida Therapeutics Inc (NASDAQ: PSTX) more than tripled this morning after Roche Holding (SWX: ROG) said it will buy the clinical-stage biopharmaceutical company for about $1.5 billion. Roche’s offer values each share of Poseida Therapeutics at $9.0 that translates to a more than 200% premium on their previous…
Borr Drilling Ltd (NYSE: BORR) is positioned for exceptional returns in 2025, as per Thiago Mordehachvili – the chief…
A recent Goldman Sachs survey suggests consumers will likely spend more on holiday shopping this year compared to 2023.…
Asian stock markets faced downward pressure on Wednesday as investors grappled with the implications of incoming US President Donald…
The Adani Group has issued a clarification regarding the charges against its founder, Gautam Adani, following a US indictment.…
Bitcoin, the largest cryptocurrency, has reversed course after flirting with the $100,000 mark. The digital asset reached an all-time…
A recent Wall Street Journal investigation has revealed potentially troubling practices within Morgan Stanley’s wealth management division. Leaked documents…
Singapore’s strategic positioning as a global financial hub continues to strengthen, with the city-state outpacing long-time rival Hong Kong.…
Apple CEO Tim Cook joined a high-profile gathering of over 20 global business leaders in Beijing on Monday, meeting…